Riskpilot← Back to searchSign inGet full accessFERONIA NORDIC AS
ASActiveOrg 821270332Fjordalléen 18, 0250 OsloNon-specialised wholesale trade · NACE 4690Est. 20180 employeesmedhelse.no
Revenue 2024
NOK 0
EBITDA margin
—
+27% vs 2023
Equity ratio
-580.9%
Financial strength
Net profit 2024
NOK -46K
-743% vs 2023
| Revenue | NOK 0 | — |
| EBITDA | NOK -46K | +27% |
| Net profit | NOK -46K | -743% |
| Total assets | NOK 326K | +100% |
| Equity | NOK -1,9M | -2% |
| Employees | 0 | — |
Legal name
FERONIA NORDIC AS
Org number
821270332
Legal form
Aksjeselskap
NACE code
4690 · Non-specialised wholesale trade
Founded
21. august 2018
Share capital
NOK 30 000
Employees
0
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Styrets leder alene.
Company purpose
Kjøp og salg av helserelaterte produkter. Tjenesteytende opplysningsvirksomhet ved bruk av helserelaterte produkter. Deltakelse i andre selskaper og annet som står i denne forbindelse.
Address
Fjordalléen 18, 0250 Oslo
Website
medhelse.no
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 151 | 179 | 95 | 0 | 0 |
| Staff expenses | 66 | −23 | −20 | −5 | −0 |
| EBITDA | −406 | −149 | −1 106 | −63 | −46 |
| Depreciation & amort. | −9 | −9 | −1 | −1 | −0 |
| EBIT | −416 | −158 | −1 108 | −64 | −46 |
| Net financials | 27 | 2 | −0 | 72 | 0 |
| Profit before tax | −389 | −156 | −1 108 | 7 | −46 |
| Tax | −0 | −0 | −0 | −0 | −0 |
| Net profit | −389 | −156 | −1 108 | 7 | −46 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 1 165 | 1 102 | 150 | 163 | 326 |
| Equity | −591 | −747 | −1 855 | −1 848 | −1 893 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 1 756 | 1 849 | 2 005 | 2 010 | 2 219 |
| Total debt | 1 756 | 1 849 | 2 005 | 2 010 | 2 219 |
EBITDA margin
-4600800.0%
This company
15.8%
Market median
-29119087% vs market
20202024
Equity ratio
-580.9%
This company
38.2%
Market median
-1621% vs market
20202024
Return on equity
-4591800.0%
This company
18.4%
Market median
-24955535% vs market
20202024
Net profit margin
-4591800.0%
This company
8.1%
Market median
-56688989% vs market
20202024
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20202024
Debt / equity
1.17×
This company
0.62×
Market median
-89% vs market
20202024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
CO Chief Executive Officer | Chief Executive Officer | 2022 |
| Former (1) | ||
AS Chief Executive Officer | Chief Executive Officer | 2020 – 2022 |
No data on file.
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 100% | 100% | 2022 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Nutra Invest As
FERONIA NORDIC AS Board members of FERONIA NORDIC AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Cato Oddsett | Chief Executive Officer | 0 companies |
| Anders Struksnæs | Chief Executive Officer | 0 companies |